Biosimilars of anti-VEGF agents in retinal diseases: a narrative review of regulatory, clinical, and pharmacoeconomic aspects
Crossref DOI link: https://doi.org/10.1186/s40942-026-00872-9
Published Online: 2026-05-30
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zong, Yuan
Fan, Qiwei
Huang, Lijun
Text and Data Mining valid from 2026-05-30
Accepted Manuscript valid from 2026-05-30
Article History
Received: 17 March 2026
Accepted: 21 May 2026
First Online: 30 May 2026
Declarations
:
: Not applicable.
: The authors declare no competing interests.